Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-8443Fax+1 608-262-7174
Education & Training
- University of Utah HealthFellowship, Hematopathology, 2005 - 2006
- University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2005
- Medical University of South CarolinaResidency, Internal Medicine, 1994 - 1997
- Loma Linda University School of MedicineClass of 1994
Certifications & Licensure
- WI State Medical License 1997 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Uncommon and Challenging Phenotypes of High-Risk Human Papillomavirus-Associated Head and Neck Carcinomas Revealed by High-Throughput Studies.Alex P Tannenbaum, Taja Lozar, Changxue Lu, Megan Schumacher, Athena Golfinos
Head and Neck Pathology. 2024-10-22 - From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.Bridget E Crossman, Regan L Harmon, Kourtney L Kostecki, Nellie K McDaniel, Mari Iida
Journal of Clinical Medicine. 2024-10-10 - 2 citationsRandomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.Mitchell R Smith, Opeyemi A Jegede, Peter Martin, Brian G Till, Samir S Parekh
Blood. 2024-09-05
Journal Articles
- Unique Dependence on Sos1 in KrasG12D-Induced LeukemogenesisDavid Yang, Erik A Ranheim, Blood
- Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative NeoplasmErik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature
Press Mentions
- Banking on Patient Samples to Advance COVID-19 ResearchNovember 20th, 2020
- Researchers Identify Mechanism Controlling Red Blood Cell DevelopmentOctober 7th, 2016
- Society of Hematopathology Quarterly Case Winter 2016: Primary Myelofibrosis with an Unusual MPL Mutation: Integrating Molecular Testing into the Diagnosis and Prognosis of BCR-ABL1 Negative Myeloproliferative Neoplasms. WMSH1601March 3rd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: